ABSTRACT
INTRODUCTION
Tuberculosis (TB) is the most common mycobacterial chronic communicable disease as stated by WHO. The major issue for many antimycobacterial agents is its resistance of Mycobacterium tuberculosis strains. In the last forty years there is no effective new anti-TB drugs have been identified with new mechanism of action. However isoniazid show severe toxicity on repeated dosing, still it is considered as the drug of choice for TB. The literature reports suggest that nearly 8 million people develop active TB every year and approximately 5,500 people die every day (www.who.int/mediacentre/factsheets/ fs104/ en//). 1, 2 It was also noticed that single drug regimen resulted in rapid development of resistance and lack of efficiency in management hence, TB has been therapeutically managed by combination therapy for more than last five decades. 1 The rationale for combination therapy to treat TB is purely based on simple probability. The risk factors such as HIV infection, previous incarceration, failed TB treatment, failure to respond to standard TB treatment, and relapse following standard TB treatment adds to the complications of Multi Drug Resistant (MDR) -TB. 2 People with HIV and latent TB infection need to be treated at the earliest to prevent active tubercular infection. People with HIV and latent TB infection are more susceptible to develop active tubercular infection than people without HIV. It was also reported that one in five people with tubercular infection are unaware of their HIV status. Center for Disease Control (CDC) recommends the screening for HIV in TB patients. 3 Recent advances in TB genome sequence like, a gene probe for rpoB, katG, 4 and mabA-inhA 5 have provided a platform for development of novel targets for drug deevelopment. 6 However no new specific and effective drug has been launched for TB in the last 40 years. 7 It is imminent to discover new structural classes of anti-tuberculosis agents.
The contribution of computational chemistry in rational drug design is an important factor to note. Quantitative structure activity rela-www.ptbreports.org tionship (QSAR) is able to identify the relationship between a molecule and its structure and how the structure influences the activity of the molecule. 8 Several QSAR models have been reported for the designing of potent anti-tubercular agents. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] As a part of our investigation, for further optimizing the quinolone anti-bacterial against Mycobacterium tuberculosis, the QSAR studies were performed on twenty 3-heteroarylthioquinoline derivatives to assess their antitubercular activity based on their physico-chemical property.
MATERIALS AND METHODS
We used Chem. Office 2004 (Cambridge Soft Corp., Cambridge, USA, http://www.cambridgesoft.com) and Molecular Modeling Pro 6.1.0 (Trial version, ChemSW, Inc., www.chemsw.com) to perform molecular modeling studies and SPSS 11.5 to develop and validate QSAR models.
Biological data
We used the biological and chemical data of twenty 3-heteroarylthioquinoline derivatives reported by Chitra et al. (2011) 21 (Table 1 ) for the present study. High structural diversity was observed in the selected series of 3-heteroarylthioquinoline derivatives and also high range of the biological activity. Anti-tubercular activity was expressed as -log MIC, where MIC is the micro molar concentration of the compounds producing minimum inhibition against Mycobacterium tuberculosis and considered as the mean of at least two experiments. The selected series was used as such for the model development since the selected series of 3-heteroarylthioquinolines contained less number of compounds.
Molecular structure optimization
Chem Office 2004 software was used for structure building and for entire modeling works. Physico-chemical descriptors were calculated by using Chem Office 2004 and Molecular Modeling Pro 6.1.0 software.
Calculation of descriptors
The various physico-chemical descriptors [ClogP (calculated partition coefficient in octanol/water), CMR (calculated molar refractivity of the whole molecule), HBD (hydrogen bond donor), HBA (hydrogen bond acceptor), B1 (measure of the width of the first atom of a substituent), B5 (overall volume of a substituent), L (substituent length), density] were calculated using the sketched molecules. (Physicochemical parameter involved in model is given in Table 1 )
QSAR model-development and validation
Descriptors were selected based on permutation and correlation matrices to prevent co-linearity problems. Stepwise multiple linear regression analysis was used to optimize the best model. The following parameters like n-number of data points, r 2 -squared correlation coefficient, F-test (Fischer value) for statistical significance, se-standard error, q 2 -cross validated correlation coefficient and correlation matrix are used in QSAR equations. 22 Leave one out -cross validation (LOO-CV) method was used for internal validation. The cross validated correlation coefficient q 2 was calculated by the given formula Where yi, and ŷi are the actual and predicted activity of the i th molecule in the training set, respectively and ymean is the average activity of all molecules in the training set. However, a high q 2 value does not necessarily give a suitable representation of the real predictive power of the model. The predictive ability of the selected model was also confirmed by r 
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Where r 2 is squared correlation coefficient between observed and predicted values and r 0 2 is squared correlation coefficient between observed and predicted values with intercept value set to zero. A value of r 2 m is greater than 0.5 indicates good external predictability.
Where y is mental data and ŷ is predicted data.
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Y-Randomization test was used to assess the robustness of a QSAR model. A new model was developed using the original independent variable matrix and the dependent variable vector randomly shuffled in this technique. The random number simulation showed that the probability of chance correlation and the degree of inflation of internal figures of merit is considerable in small data sets and in the case of low object-to-variable ratios. 26 Hence Y-randomization test has become a common practice in QSAR studies. The new QSAR models (after several repetitions) are expected to provide low R 2 and Q 2 values, otherwise an acceptable QSAR model cannot be obtained for the specific modeling method.
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RESULTS AND DISCUSSION
The best model generated by stepwise multiple linear regression analysis is identified as Model-1.
Model-1:
-logMIC=-7.172 (± 0.723) + 2.795 (± 0.354) Density Table 1 . The residual plot between experimental and calculated anti-tubercular activities of 3-heteroarylthioquinoline derivatives is given in Figure 1 .
The significance and predictive ability of the proposed Model-1 was confirmed as it satisfied the following conditions: William's plot of standardized residuals (y-axis) versus leverages (x-axis) for each compound of the training set was shown in Figure  2 . The applicability domain was established inside a squared area within ± 1.75 standard deviations and a leverage threshold h*=0.375 (h*=3p´/n, being p´ the number of model parameters + 1, and n the number of compounds). All compounds of training set and test set were seen inside of the square area.
For future investigations, the predicted anti-tubercular activity data must be considered only if the molecules fall within the applicability domain on which the model was constructed.
Moreover the reported QSAR models are not used to predict the activity of any type of molecules vs. anti-tubercular activity. However, it is very important to highlight the eventual QSAR models disappointments: activity cliffs. 30 It is possible because similar molecules can exhibit different biological activity. Activities are often mispredicted for these molecules, even though the overall prediction of these models is high.
The positive contribution of density to anti-mycobacterium activity indicates that highly dense (more volume) groups are advantageous for anti-mycobacterium activity. The molecules may not fit into the binding site when they have less volume. The presence of bromo or chloro substituted benzene at "Ar" could provide potent anti-mycobacterium compounds which is evident from the data of the compounds 3, 4, 7 and 11. Our study findings support the reports of Chitra et al. (2011) 19 which indicated that the presence of halogens in the aryl ring (compounds 3, 4 and 11) enhances the anti-mycobacterium activity.
CONCLUSION
We had developed a QSAR model for a set of twenty3-heteroarylthioquinoline derivatives having Mycobacterium tuberculosis inhibitory activity. The LOO cross-validation methods and Y-randomization technique suggested that the model was significant, robust and possess good internal predictability. The result findings can be utilized in the development and optimization of novel antitubercular agents. The reported QSAR models in the manuscript might be used for predicting the anti-tubercular activity of 3-heteroarylthioquinoline derivatives only. We also suggest to performing 3D QSAR and docking studies to understand the mechanisms of chemical-biological interactions of 3-heteroarylthioquinolines against Mycobacterium tuberculosis.
